Mesothelioma Drug Trials

LOS ANGELES, May 16, 2012 /PRNewswire/ — At the 2nd Annual Symposium for Lung-Sparing Therapies for Malignant Pleural Mesothelioma held this weekend at the Sheraton Delfina in Santa Monica, CA, international experts again re-affirmed the … View full post on mesothelioma – Bing News

Malignant pleural mesothelioma is a rare malignancy with a dismal prognosis. The clinical management of most of the patients with this disease is quite challenging, and, overall, the therapeutic strategy has not yet benefited from the recent … View full post on mesothelioma – Bing News

DUBLIN– — Dublin – Research and Markets has announced the addition of Global Markets Direct's new report "Malignant Mesothelioma – Pipeline Review, H1 2012" to their offering. Global Markets Direct's, 'Malignant Mesothelioma – Pipeline Review, H1 2012', provides an overview of the Malignant Mesothelioma therapeutic pipeline. This report provides information on the therapeutic development … [...]

Mesothelioma experts will gather on Saturday, May 12th 2012 at the Sheraton Delfina in Santa Monica, CA for the 2nd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma. Dr. Robert Cameron, Director of the UCLA … View full post on mesothelioma – Bing News

LOS ANGELES, Feb. 21, 2012 /PRNewswire/ – Mesothelioma experts will gather on Saturday, May 12th 2012 at the Sheraton Delfina in Santa Monica, CA for the 2nd Annual International Symposium on Lung-Sparing … View full post on mesothelioma – Yahoo! News Search Results

Research and Markets has announced the addition of Global Markets Direct’s new report “Malignant Mesothelioma View full post on mesothelioma – Yahoo! News Search Results

Editor’s Note: Malignant pleural mesothelioma is a rare, difficult-to-treat cancer that is seen primarily in older men who were exposed to asbestos many decades earlier. In 2003, the addition of pemetrexed to cisplatin as a first-line treatment … View full post on mesothelioma – Bing News

BANNOCKBURN, Ill. , Dec. 14, 2011 /PRNewswire/ – Pinnacle Biologics, Inc., a privately held specialty bio-pharmaceutical company announced today that it has obtained approval for an Orphan Drug Designation (ODD) for their product PHOTOFRIN … View full post on mesothelioma – Bing News

Research and Markets(http://www.researchandmarkets.com/research/b6694b/malignant_mesothel) has announced the addition of GlobalData ‘s new report “Malignant Mesothelioma Therapeutics – Pipeline Assessment and Market Forecasts to 2017″ to their offering … View full post on mesothelioma – Bing News

DUBLIN–(BUSINESS WIRE)–Research and Markets(http://www.researchandmarkets.com/research/b6694b/malignant_mesothel) has announced the addition of GlobalData ‘s new report “Malignant Mesothelioma Therapeutics – Pipeline Assessment and Market Forecasts to 2017″ to their offering. GlobalData, the industry analysis specialist, has released its new report, Malignant Mesothelioma Therapeutics … View full post on mesothelioma – Yahoo! News Search Results